- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Jersey City Pharmacy Reaches $4.3M Settlement in Drug Fraud Case
Four Hudson County pharmacies accused of billing for medications they never dispensed
Jan. 28, 2026 at 7:55am
Got story updates? Submit your updates here. ›
Four Hudson County pharmacies, including one in Jersey City, have agreed to pay more than $4.3 million to resolve allegations that they violated federal law by knowingly billing health care programs for medications they never actually dispensed, according to Philip Lamparello, senior counsel in the United States Attorney's Office, District of New Jersey.
Why it matters
This settlement highlights ongoing efforts by federal authorities to crack down on healthcare fraud, which costs taxpayers billions each year. The case also underscores the need for robust oversight and accountability measures in the pharmaceutical supply chain to prevent abuse of government healthcare programs.
The details
According to the settlement agreements, inventory records showed the pharmacies did not purchase enough medications from wholesalers to fill the prescriptions they billed to federal health care programs. The businesses were alleged to be in violation of the federal False Claims Act.
- The settlement agreements were announced recently.
The players
Philip Lamparello
Senior counsel in the United States Attorney's Office, District of New Jersey.
United States Attorney's Office, District of New Jersey
The federal agency that announced the settlement agreements.
The takeaway
This case highlights the ongoing efforts by federal authorities to combat healthcare fraud and the importance of ensuring accountability and transparency in the pharmaceutical supply chain to protect taxpayer-funded programs.
Jersey City top stories
Jersey City events
Mar. 19, 2026
Gary NumanMar. 21, 2026
Emo Night Karaoke


